Lumendi unveils EZ Glide for DiLumen endoluminal interventional platform 

30 March 2021 (Last Updated March 30th, 2021 10:33)

Lumendi has unveiled a new hydrophilic coating, EZ Glide, which is applied to the inner sheath of its DiLumen Endoluminal Interventional Platform (EIP).

Lumendi unveils EZ Glide for DiLumen endoluminal interventional platform 
DiLumen EIP can safely improve the navigation of the endoscope through the bowel and create a stabilised therapeutic zone inside the colon during endoluminal interventions. Credit: JimCoote from Pixabay.

Lumendi has unveiled a new hydrophilic coating, EZ Glide, which is applied to the inner sheath of its DiLumen Endoluminal Interventional Platform (EIP).

Activated by water or saline, EZ Glide can boost the endoscopic performance of the DiLumen EIP by providing additional stability to the endoscope tip and nearby anatomy.

It can offer gentle anatomic control for safely straightening and transversing tortuous anatomy, providing enhanced control and quicker access to lesions.

Furthermore, the coating lessens the need for other gels or oils during preparation, which can enhance intraoperative visibility. It also permits safe and continuous access as a conduit, facilitating the efficient exchange of tools and removal of tissues.

A double-balloon endoluminal device, DiLumen EIP can safely improve the navigation of the endoscope through the bowel, make a stabilising therapeutic zone inside the colon during endoluminal interventions and aid in lowering potential mucosal injury.

The device has a soft flexible sheath that fits over standard and small diameter endoscopes.

It uses two balloons, the first behind the bending section of the endoscope and the second in front of the tip. When inflated, the area in between them becomes a stabilised therapeutic zone.

This zone enables stabilisation, insufflation and manipulation of the tissue, helping clinicians to treat target areas in a more effective manner.

On completing the procedure, the balloons can be deflated and removed along with the endoscope.

Lumendi CEO Dr Peter Johann said: “The DiLumen EIP has the potential to improve or enable less invasive procedures for benign colorectal polyps, and can take the place of open or laparoscopic surgery, thereby preserving anatomy, shortening recovery and reducing healthcare costs.”

Johann added that researchers at the University of Florida in Gainesville, US, concluded that surgery is greatly overused in treating benign colorectal polyps.